Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Behavioral Disorders - Opportunities To Shape Future Markets

Published by: Datamonitor

Published: Apr. 14, 2003 - 47 Pages


Table of Contents



About Datamonitor

About the CNS pharmaceutical analysis teams

EXECUTIVE SUMMARY

Introduction

Scope and coverage of the brief

INTRODUCTION

BEHAVIORAL DISORDERS USUALLY DIAGNOSED IN INFANCY,
CHILDHOOD, OR ADOLESCENCE


TOURETTE’S SYNDROME

CONDUCT DISORDER

IMPULSE-CONTROL DISORDERS NOT ELSEWHERE
CLASSIFIED


TRICHOTILLOMANIA

PATHOLOGICAL GAMBLING

KLEPTOMANIA

INTERMITTENT EXPLOSIVE DISORDER

APPENDIX

Bibliography

Websites

Abstract

Introduction
Over the last decade, behavioral disorders have received increasing attention from the media and medical professionals, but only attention deficit / hyperactivity disorder (ADHD) has emerged as a key market. Including data from the Datamonitor's proprietary Behavioral Disorders Survey 2003, this Market Brief discusses strategies to grow the markets for non-ADHD behavioral disorders.

Scope
Data from Datamonitor’s Behavioral Disorder Survey 2003, which interviewed physicians from the US, Japan, France, Germany, Italy, Spain and the UK

Analysis of Tourette’s syndrome, conduct disorder, trichotillomania, pathological gambling, kleptomania, and intermittent explosive disorder

Primary and secondary data are used in an analysis of epidemiological metrics, use of pharmacotherapies and strategies to overcome market barriers

Report Highlights
A number of issues, such as a lack of robust epidemiology data, low public and physician awareness regarding aetiology, has ensured that significant barriers to entry exist for manufacturers aiming to penetrate non-ADHD behavioral disorder markets.

Although there are significant barriers to entry, Datamonitor believes that there are opportunities for marketed drugs to penetrate non-ADHD behavioral disorders. These include Lilly’s Straterra and Janssen’s Risperdal, however, each company will have to decide whether to attempt to gain an indication or simply promote off label use.

Reasons to Purchase
Understand the market barriers and how to minimize these

Enhance knowledge of treatment strategies for behavioral disorders

Understand how the behavioral disorder markets can be linked to increase patient potential increase potential revenues



Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options

Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008